Citation: F. Veiga et al., ORAL CONTROLLED-RELEASE DOSAGE FORMS - II - GLASSY-POLYMERS IN HYDROPHILIC MATRICES, Drug development and industrial pharmacy, 24(1), 1998, pp. 1-9
Citation: T. Salsa et al., ORAL CONTROLLED-RELEASE DOSAGE FORMS .1. CELLULOSE ETHER POLYMERS IN HYDROPHILIC MATRICES, Drug development and industrial pharmacy, 23(9), 1997, pp. 929-938
Citation: F. Veiga et al., INFLUENCE OF TECHNOLOGICAL VARIABLES ON THE RELEASE OF THEOPHYLLINE FROM HYDROPHILIC MATRIX TABLETS, Drug development and industrial pharmacy, 23(6), 1997, pp. 547-551
Citation: S. Simoes et al., USING A PARTICLE COUNTER TO ASSESS IN-VITRO DISSOLUTION STUDIES, International journal of pharmaceutics, 131(2), 1996, pp. 273-276
Authors:
VEIGA F
TEIXEIRADIAS JJC
KEDZIEREWICZ F
SOUSA A
MAINCENT P
Citation: F. Veiga et al., INCLUSION COMPLEXATION OF TOLBUTAMIDE WITH BETA-CYCLODEXTRIN AND HYDROXYPROPYL-BETA-CYCLODEXTRIN, International journal of pharmaceutics, 129(1-2), 1996, pp. 63-71
Citation: A. Alvarez et al., FUNCTIONAL, HISTOLOGIC, AND ULTRASTRUCTURAL-STUDY OF THE PROTECTIVE EFFECTS OF VERAPAMIL IN EXPERIMENTAL ISCHEMIC ACUTE-RENAL-FAILURE IN THE RABBIT, Renal failure, 16(2), 1994, pp. 193-207
Citation: F. Veiga et al., CHARACTERIZATION OF THE IN-VITRO DISSOLUTION OF SOME COMMERCIAL SUSTAINED-RELEASE THEOPHYLLINE DOSAGE FORMS, Drug development and industrial pharmacy, 20(8), 1994, pp. 1471-1483